Direkt zum Inhalt
Merck
  • The effect of oestradiol valerate therapy on coagulation factors and lipid and oestrogen levels in oöphorectomised women.

The effect of oestradiol valerate therapy on coagulation factors and lipid and oestrogen levels in oöphorectomised women.

The Australian & New Zealand journal of obstetrics & gynaecology (1978-08-01)
D M Saunders, J C Hunter, D A Shutt, B J O'Neill
PMID283783
ZUSAMMENFASSUNG

The effect of oestradiol valerate on levels of blood cholesterol, triglycerides, free oestradiol and coagulation factors, as well as on urinary oestrogens and free cortisol was measured in 10 oöphorectomised women. Despite the very high urinary oestrogen levles obtained, there was no significant change found in the other parameters during and after treatment. These findings are discussed, as is the significance of the metabolism of both endogenously produced and orally administered oestrogens in the menopausal woman.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Valeriansäure, ≥99%
Sigma-Aldrich
Valeriansäure, ≥99%, FCC, FG
Supelco
Valeriansäure, analytical standard